Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Experts call for EU ban on diclophenic
vulture
The paper blames diclophenac for the near-extinction of vultures in Pakistan, India and Nepal in the 1990s.

Research paper warns of the risks of veterinary pharmaceuticals to wildlife

Experts are calling for an EU-wide ban on the use of diclophenac in livestock, as it is placing fragile vulture populations at risk.

According to research published in the journal Science this week, a "one health" approach is needed to address the dangers of veterinary pharmaceuticals to wildlife.

Even traces of the drug in livestock carcasses are fatal to the vultures who feed on them. Contamination of less than 1 per cent of carcasses previously led to the near extinction of three Asian species. For this reason, veterinary use of diclophenac has already been banned in many South Asian countries.

Dr Lisa Yon from the University of Nottingham's School of Veterinary Medicine, said: "It is clear from the lessons learned on the profound impact of diclofenac on vultures in India that we need to take a more integrated, 'one Health' approach to our use of VPs, and the larger impact they have on non-target species, and on the environment. 

"This is and will continue to be an issue of increasing concern for a wide variety of VPs, and one for which there needs to be greater responsibility taken across the range of stakeholders."

Last year, diclophenac was authorised for use in cattle, pigs and horses in Spain, where more than 95 per cent of the continent's vultures reside.

Spanish vultures help to control pests and disease by removing more than 8,000 tonnes of livestock caresses each year. This is estimated to save the economy €1.5 million annually.

Lead author of the research was Thijs Kuiken, professor of Comparative Pathology at the Erasmus Medical Centre. He said he was "shocked" that the drug had been authorised in Spain. "This example shows that we need to radically change the way we deal with pharmaceuticals, both those used in human and veterinary medicine."

The paper, titled "One health approach to use of veterinary pharmaceuticals", blames diclophenac for the near-extinction of vultures in Pakistan, India and Nepal in the 1990s. Veterinary diclophenac products were banned in India in 2006 and Pakistan, Nepal and Bangladesh followed suit shortly after. Experts say vulture declines have slowed or reversed in South Asia since the ban.

Co-author Martin Gilbert, a Wildlife Conservation Society vet, said the loss of vultures in South Asia was a "tragedy". He warned that unless action is taken, the situation could occur in Europe.

For the full study, visit: http://www.sciencemag.org/content/early/2014/12/03/science.1260260

Image ©Wikipedia/CC BY-SA 2.5/Thermos

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.